143 related articles for article (PubMed ID: 31581637)
1. Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail.
Bosilkovska M; Magliocco G; Desmeules J; Samer C; Daali Y
J Pers Med; 2019 Oct; 9(4):. PubMed ID: 31581637
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
[TBL] [Abstract][Full Text] [Related]
3. Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.
Bosilkovska M; Samer CF; Déglon J; Rebsamen M; Staub C; Dayer P; Walder B; Desmeules JA; Daali Y
Clin Pharmacol Ther; 2014 Sep; 96(3):349-59. PubMed ID: 24722393
[TBL] [Abstract][Full Text] [Related]
4. Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins.
Rollason V; Mouterde M; Daali Y; Čížková M; Priehodová E; Kulichová I; Posová H; Petanová J; Mulugeta A; Makonnen E; Al-Habsi A; Davidson R; Al-Balushi KK; Al-Thihli K; Cerná M; Al-Yahyaee S; Černý V; Yimer G; Poloni ES; Desmeules J
Drug Saf; 2020 Nov; 43(11):1181-1189. PubMed ID: 32851583
[TBL] [Abstract][Full Text] [Related]
5. Effect of fermented red ginseng on cytochrome P450 and P-glycoprotein activity in healthy subjects, as evaluated using the cocktail approach.
Kim MG; Kim Y; Jeon JY; Kim DS
Br J Clin Pharmacol; 2016 Dec; 82(6):1580-1590. PubMed ID: 27495955
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.
Bosilkovska M; Déglon J; Samer C; Walder B; Desmeules J; Staub C; Daali Y
Bioanalysis; 2014 Jan; 6(2):151-64. PubMed ID: 24423593
[TBL] [Abstract][Full Text] [Related]
7. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
8. Effect of Red Ginseng on cytochrome P450 and P-glycoprotein activities in healthy volunteers.
Kim DS; Kim Y; Jeon JY; Kim MG
J Ginseng Res; 2016 Oct; 40(4):375-381. PubMed ID: 27746690
[TBL] [Abstract][Full Text] [Related]
9. Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study).
Lloret-Linares C; Daali Y; Chevret S; Nieto I; Molière F; Courtet P; Galtier F; Richieri RM; Morange S; Llorca PM; El-Hage W; Desmidt T; Haesebaert F; Vignaud P; Holtzmann J; Cracowski JL; Leboyer M; Yrondi A; Calvas F; Yon L; Le Corvoisier P; Doumy O; Heron K; Montange D; Davani S; Déglon J; Besson M; Desmeules J; Haffen E; Bellivier F
BMC Pharmacol Toxicol; 2017 Nov; 18(1):70. PubMed ID: 29115994
[TBL] [Abstract][Full Text] [Related]
10. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
[TBL] [Abstract][Full Text] [Related]
11. Validation of a bupropion, dextromethorphan, and omeprazole cocktail for simultaneous phenotyping of cytochrome P450 2B11, 2D15, and 3A12 activities in dogs.
Martinez SE; Jimenez TEP; Court MH
Am J Vet Res; 2024 May; ():1-10. PubMed ID: 38718826
[TBL] [Abstract][Full Text] [Related]
12. Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.
Derungs A; Donzelli M; Berger B; Noppen C; Krähenbühl S; Haschke M
Clin Pharmacokinet; 2016 Jan; 55(1):79-91. PubMed ID: 26123704
[TBL] [Abstract][Full Text] [Related]
13. Can the CEIBA Cocktail Designed for Human Cytochrome P450 Enzymes be Used in the Rat for Drug Interaction Studies?
Magalhães P; De Andrés F; Falcão A; LLerena A; Alves G
J Pharm Pharm Sci; 2016; 19(4):520-529. PubMed ID: 28057170
[TBL] [Abstract][Full Text] [Related]
14. Investigation on modulation of human P-gp by multiple doses of Radix Astragali extract granules using fexofenadine as a phenotyping probe.
Zhou Q; Ye Z; Ruan Z; Zeng S
J Ethnopharmacol; 2013 Apr; 146(3):744-9. PubMed ID: 23422332
[TBL] [Abstract][Full Text] [Related]
15. Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs.
Darnaud L; Delage C; Daali Y; Trouvin AP; Perrot S; Khoudour N; Merise N; Labat L; Etain B; Bellivier F; Lloret-Linares C; Bloch V; Curis E; Declèves X
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986840
[TBL] [Abstract][Full Text] [Related]
16. Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
Lenoir C; Daali Y; Rollason V; Curtin F; Gloor Y; Bosilkovska M; Walder B; Gabay C; Nissen MJ; Desmeules JA; Hannouche D; Samer CF
Clin Pharmacol Ther; 2021 Jun; 109(6):1668-1676. PubMed ID: 33341941
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous and comprehensive in vivo analysis of cytochrome P450 activity by using a cocktail approach in rats.
Uchida S; Tanaka S; Namiki N
Biopharm Drug Dispos; 2014 May; 35(4):228-36. PubMed ID: 24395703
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination.
Kharasch ED; Walker A; Hoffer C; Sheffels P
J Clin Pharmacol; 2005 Jan; 45(1):79-88. PubMed ID: 15601808
[TBL] [Abstract][Full Text] [Related]
19. The Development and Validation of a Novel "Dual Cocktail" Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions.
Kwon M; Jeon JH; Choi MK; Song IS
Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 33007943
[TBL] [Abstract][Full Text] [Related]
20. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
